Table 3.
Preliminary outcomes of the pilot randomized controlled trial of RAP (N = 23)
| Baseline | 1-Month | 3-Month | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| RAP Intervention (N = 12) | Attention-Control (N = 11) | RAP Intervention (N = 12) | Attention-Control (N = 10) | RAP Intervention (N = 12) | Attention-Control (N = 10) | |
| M (SD) | M (SD) | M (SD) | M (SD) | M (SD) | M (SD) | |
| IES-R | ||||||
| Modified Total Score | 25.0 (18.6) | 17.8 (13.9) | 26.2 (15.1) | 13.3 (15.5) | 23.5 (11.2) | 10.0 (12.7)* |
| Intrusion Subscale | 11.9 (9.9) | 9.4 (6.6) | 12.7 (8.9) | 6.7 (6.4) | 11.2 (6.7) | 6.1 (7.3) |
| Avoidance Subscale | 13.1 (9.6) | 8.5 (8.3) | 13.5 (8.4) | 6.6 (10.0) | 12.3 (8.5) | 3.9 (6.5)* |
| HIV Transmission Risk | ||||||
| Total Partners | 2.0 (2.7) | 1.2 (2.9) | - | - | 0.5 (1.2) | 0.5 (1.6) |
| Partners on Meth | 1.8 (2.6) | 1.2 (2.9) | - | - | 0.2 (0.6)* | 0.0 (0.0) |
| Stimulant Use | ||||||
| Meth Use (Past 30 Days) | 5.3 (4.0) | 7.6 (8.4) | 2.9 (4.6)** | 9.1 (10.8) | 5.3 (10.2) | 7.4 (9.7) |
| N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |
| Tox+ for Stimulants | 6 (50) | 6 (54) | 7 (58) | 6 (55) | 7 (58) | 7 (64) |
Meth = Methamphetamine; Tox+ = Urine sample reactive for stimulants;
*
p < .05